ATLASSkye Bioscience (SKYE) earnings date: Nov 9, 2026
Skye Bioscience (SKYE) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of -$1.12.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SKYE
| Last price | $1.33 (+3.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Skye Bioscience stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Skye Bioscience reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Skye Bioscience. You can switch it off at any time.
Alert me before SKYE reportsFree to start. Creating an account takes under a minute.
Notify me when Skye Bioscience reports
Track SKYE free Add Skye Bioscience to a free ATLAS watchlist and see its next report date in one place.
SKYE earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.12 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +3.0% |
| Average move around a report | ±7.9% (last 4) |
| Sector | Healthcare · Biotechnology |
Skye Bioscience earnings history: last 4 reports
Skye Bioscience last reported on Aug 14, 2026: EPS of -$1.55 against an estimate of -$2.11 (+26.5% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$2.11 | -$1.55 | +26.5% | Beat | -23.3% |
| Jul 21, 2026 | $1.55 | $1.62 | +4.5% | Beat | -2.1% |
| May 11, 2026 | -$2.59 | -$2.56 | +1.2% | In line | -5.7% |
| Mar 10, 2026 | -$2.45 | -$2.95 | -20.4% | Miss | -0.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SKYE
See the fair value, the probability range and the earnings history of Skye Bioscience on its ATLAS page.
Skye Bioscience (SKYE) stock analysisPlans from €3.99 a month.
Skye Bioscience earnings: frequently asked questions
When does Skye Bioscience (SKYE) report earnings?
Skye Bioscience is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for SKYE?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.12 per share (USD). Estimates can change before the report.
How often does SKYE beat earnings estimates?
Of its last 4 reports with a recorded result, Skye Bioscience beat the EPS estimate 2 times; the average surprise was +3.0%. Past results do not predict the next one.
How much does SKYE move around earnings?
Over its last 4 reports the stock moved an average of 7.9% (absolute, from the close before the report day to the close after it), and finished higher 0 of 4 times.
Did Skye Bioscience beat earnings estimates last quarter?
Skye Bioscience last reported on Aug 14, 2026: EPS of -$1.55 against an estimate of -$2.11 (+26.5% surprise), a beat.
How much does SKYE usually move in a day?
On a normal trading day the ATLAS model puts SKYE’s one-day range at about ±10.5%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer